There has been considerable academic interest in recent years in supply chain resilience
(SCRES). This paper presents a timely review of the available literature on SCRES based …

Background: Falsified medicines are deliberately fraudulent drugs that pose a direct risk to
patient health and undermine healthcare systems, causing global morbidity and mortality …

Purpose In few prior empirical studies on supply chain resilience (SCRES), the focus has
been on the developed world. Yet, organisations in developing countries constitute a …

The production of counterfeit drugs is a broad and under reported problem particularly
affecting poorer countries. It is an important cause of unnecessary mortality and morbidity …

It has been widely suggested that the global market in counterfeit, falsified and illegally
traded medicines has expanded at a tremendous rate in recent years, offering lucrative …

Background: The supply chain risk management (SCRM) process is aimed at the
implementation of strategies that assist in managing both daily and exceptional risks facing …

Background A recent systematic review suggested that drug registrations and onsite quality
inspections may be effective in reducing the prevalence of counterfeit and substandard …

The world is facing the problem of substandard or spurious drugs. These substandard drugs
have resulted in life threatening issues, financial loss of consumer and manufacturer and …

Hospice and palliative care development, in terms of availability and services, occur to
varying degrees in the developing world. In this paper, the evolution of palliative care …

Background. The illicit trade in counterfeit antimalarial drugs is a major setback to the fight
against malaria. Information on public awareness and ability to identify counterfeit drugs is …